Last updated on November 2019

A Study of Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of baricitinib as monotherapy in participants with moderate to severe atopic dermatitis.

Clinical Study Identifier: NCT03334396

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.